ThermoGenesis Corp. (NASDAQ: KOOL) has their focus on the regenerative medicine market. This focus inspired the company to create a wholly-owned subsidiary named Vantus Inc. This subsidiary is a veterinary stem cell laboratory service that has collaborations with the UC Davis School of Veterinary Medicine’s Center for Equine Health and its Stem Cell Regenerative Medicine group to conduct research and development to enhance the collecting, processing, and storing of stem cells. For further information, visit the Company’s web site at www.thermogenesis.com.
- 18 years ago
QualityStocks
ThermoGenesis Corp. (NASDAQ: KOOL)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Hallmark Venture Group, Inc. (OTC: HLLK) Completes Drone Technology Acquisition, Transitions to Operating Business
Hallmark Venture Group (OTC: HLLK) announced the completion of a strategic transaction that transforms the company from…
-
QualityStocksNewsBreaks – Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Featured in BioMedWire Editorial on DNA Repair Cancer Therapies
This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced…
-
QualityStocksNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Releases RoadSight UGV Demonstration Video
Safe Pro Group (NASDAQ: SPAI), has released a demonstration video highlighting its new RoadSight capability,…